MA23650A1 - Sels d'un derive d'indole, son procede de production et composition le contenant - Google Patents

Sels d'un derive d'indole, son procede de production et composition le contenant

Info

Publication number
MA23650A1
MA23650A1 MA23992A MA23992A MA23650A1 MA 23650 A1 MA23650 A1 MA 23650A1 MA 23992 A MA23992 A MA 23992A MA 23992 A MA23992 A MA 23992A MA 23650 A1 MA23650 A1 MA 23650A1
Authority
MA
Morocco
Prior art keywords
same
salts
producing
composition containing
indole derivative
Prior art date
Application number
MA23992A
Other languages
English (en)
Original Assignee
Pfizer Res And Dev Company Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10760474&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA23650(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Res And Dev Company Sa filed Critical Pfizer Res And Dev Company Sa
Publication of MA23650A1 publication Critical patent/MA23650A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Anesthesiology (AREA)
  • Nutrition Science (AREA)
  • Toxicology (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Reciprocating, Oscillating Or Vibrating Motors (AREA)
MA23992A 1994-08-27 1995-08-21 Sels d'un derive d'indole, son procede de production et composition le contenant MA23650A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9417310A GB9417310D0 (en) 1994-08-27 1994-08-27 Therapeutic agents

Publications (1)

Publication Number Publication Date
MA23650A1 true MA23650A1 (fr) 1996-04-01

Family

ID=10760474

Family Applications (1)

Application Number Title Priority Date Filing Date
MA23992A MA23650A1 (fr) 1994-08-27 1995-08-21 Sels d'un derive d'indole, son procede de production et composition le contenant

Country Status (45)

Country Link
US (2) US6110940A (fr)
EP (1) EP0776323B1 (fr)
JP (1) JP2904588B2 (fr)
KR (1) KR100228952B1 (fr)
CN (1) CN1066727C (fr)
AP (1) AP576A (fr)
AT (1) ATE163182T1 (fr)
AU (1) AU691005B2 (fr)
BG (1) BG61840B1 (fr)
BR (1) BRPI9503812B1 (fr)
CA (1) CA2198599C (fr)
CO (1) CO4410334A1 (fr)
CZ (1) CZ287693B6 (fr)
DE (1) DE69501620T2 (fr)
DK (1) DK0776323T3 (fr)
DZ (1) DZ1923A1 (fr)
EG (1) EG23822A (fr)
ES (1) ES2112650T3 (fr)
FI (1) FI113768B (fr)
GB (1) GB9417310D0 (fr)
GR (1) GR3026475T3 (fr)
HR (1) HRP950460B1 (fr)
HU (1) HU227822B1 (fr)
IL (1) IL115013A (fr)
IS (1) IS1850B (fr)
LV (1) LV11800B (fr)
MA (1) MA23650A1 (fr)
MX (1) MX9701538A (fr)
MY (1) MY113733A (fr)
NO (1) NO311297B1 (fr)
NZ (1) NZ288210A (fr)
OA (1) OA10600A (fr)
PE (1) PE41596A1 (fr)
PL (1) PL180867B1 (fr)
RO (1) RO116400B1 (fr)
RU (1) RU2159241C2 (fr)
SA (1) SA95160156B1 (fr)
SI (1) SI9520091B (fr)
SK (1) SK282922B6 (fr)
TN (1) TNSN95092A1 (fr)
TR (1) TR199501061A2 (fr)
UA (1) UA45980C2 (fr)
WO (1) WO1996006842A1 (fr)
YU (1) YU49287B (fr)
ZA (1) ZA957142B (fr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9420529D0 (en) 1994-10-12 1994-11-30 Pfizer Ltd Indoles
GB9706089D0 (en) * 1997-03-24 1997-05-14 Scherer Ltd R P Pharmaceutical composition
BR9810658A (pt) * 1997-07-03 2000-10-03 Pfizer Composições farmacêuticas contendo hemissulfato de eletriptano e cafeìna.
GB9714081D0 (en) * 1997-07-03 1997-09-10 Pfizer Ltd Pharmaceutical compositions
GB9816556D0 (en) * 1998-07-30 1998-09-30 Pfizer Ltd Therapy
GB9825988D0 (en) * 1998-11-27 1999-01-20 Pfizer Ltd Indole derivatives
GB9922963D0 (en) * 1999-09-28 1999-12-01 Pfizer Ltd Polymorphic salt
GB9915231D0 (en) 1999-06-29 1999-09-01 Pfizer Ltd Pharmaceutical complex
GB9923314D0 (en) 1999-10-01 1999-12-08 Pfizer Ltd Acylation process
JP2001172178A (ja) * 1999-10-25 2001-06-26 Pfizer Prod Inc 偏頭痛治療用のｎｋ−１レセプターアンタゴニスト及びエレトリプタン
US7108970B2 (en) 2000-01-07 2006-09-19 Transform Pharmaceuticals, Inc. Rapid identification of conditions, compounds, or compositions that inhibit, prevent, induce, modify, or reverse transitions of physical state
US20040252299A9 (en) 2000-01-07 2004-12-16 Lemmo Anthony V. Apparatus and method for high-throughput preparation and spectroscopic classification and characterization of compositions
GB0008563D0 (en) 2000-04-07 2000-05-24 Cambridge Discovery Chemistry Investigating different physical and/or chemical forms of materials
GB0018968D0 (en) * 2000-08-02 2000-09-20 Pfizer Ltd Particulate composition
US20030166704A1 (en) * 2000-12-20 2003-09-04 Pfizer Inc. New process
US6579898B2 (en) 2001-03-01 2003-06-17 Pfizer Inc. Compositions having improved bioavailability
WO2004089365A1 (fr) 2003-04-11 2004-10-21 Pfizer Limited Combinaison pharmaceutique a base d'eletriptan et de bicarbonate de sodium
GB0312478D0 (en) * 2003-05-30 2003-07-09 Pfizer Ltd Improved process
US7132549B2 (en) 2003-05-30 2006-11-07 Pfizer Inc. Process
US6927296B2 (en) 2003-07-23 2005-08-09 Pfizer Inc. Process
GB0317229D0 (en) * 2003-07-23 2003-08-27 Pfizer Ltd Improved process
EP1896002A4 (fr) * 2005-06-27 2009-11-25 Biovail Lab Int Srl Formulations a liberation modifiee d'un sel de bupropion
CN101687788A (zh) * 2006-10-19 2010-03-31 奥斯拜客斯制药有限公司 取代的吲哚
US20080139510A1 (en) * 2006-12-07 2008-06-12 Abe Rose Treatment of migraine headaches with sublingual amino acids
EP1956018A1 (fr) * 2007-02-06 2008-08-13 Boehringer Ingelheim Pharma GmbH & Co. KG Procédé de préparation d'un dérivé du benzimidazole
WO2008137134A2 (fr) * 2007-05-01 2008-11-13 Teva Pharmaceuticals Usa, Inc. Bromhydrate d'élétriptan amorphe et son procédé de préparation, et autres formes de bromhydrate d'élétriptan
WO2008150500A1 (fr) * 2007-05-29 2008-12-11 Plus Chemicals, S.A. Procédé pour préparer du 5-bromo-3-[(r)-1-méthyl-pyrrolidin-2-yl-méthyl]-1h-indole
US20100285075A1 (en) * 2007-12-17 2010-11-11 Actavis Group Ptc Ehf Novel Hemioxalate Salt of Eletriptan
US20090299077A1 (en) * 2008-05-22 2009-12-03 Vinod Kumar Kansal Salts of (R)-5-(2phenylsulphonylethenyl)-3-(N-methylpyrrolidin-2-ylmethyl)-1H-indole, 5-bromo-3-[(R)-1-methyl-pyrrolidin-2-ylmethyl]-1H-indole and of eletriptan
WO2010015692A2 (fr) 2008-08-07 2010-02-11 Biovail Laboratories International Srl Polymorphes de bromhydrate de bupropion
WO2010097703A1 (fr) * 2009-02-25 2010-09-02 Actavis Group Ptc Ehf Elétriptan de pureté élevée ou un de ses sels pharmaceutiquement acceptables essentiellement exempt d'impuretés n-oxydes d'élétriptan
WO2010116386A2 (fr) * 2009-04-08 2010-10-14 Biophore India Pharmaceuticals Pvt. Ltd. Nouveau polymorphe de bromhydrate d'életriptan et son procédé de fabrication
IT1393700B1 (it) 2009-04-22 2012-05-08 F S I Fabbrica Italiana Sint Sintesi di 3-{[(2r)-1-metilpirrolidin-2-il]metil}-5-[2-(fenilsulfonil)etil]-1h-indolo
WO2011004391A2 (fr) 2009-06-25 2011-01-13 Matrix Laboratories Ltd Procédé amélioré d'élaboration d'élétriptane et son sel correspondant
US8754239B2 (en) 2010-01-19 2014-06-17 Sms Pharmaceuticals Limited Process for preparing eletriptan hydrobromide having α-form
WO2014063752A1 (fr) 2012-10-26 2014-05-01 Synthon Bv Procédé de production de la forme cristalline alpha du bromhydrure d'élétriptan
JP2019502761A (ja) 2016-01-21 2019-01-31 ラボラトリオス レヴィ エセエレ （（ｒ）−３−［（−１−メチルピロリジン−２−イル）メチル］−５−（２−フェニルスルホニルエチル）−１ｈ−インドールを作製する方法

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2773875A (en) * 1952-03-28 1956-12-11 Hoffmann La Roche Indole derivatives and method for producing same
GB886684A (en) * 1957-09-17 1962-01-10 Upjohn Co Improvements in or relating to heterocyclic compounds and the manufacture thereof
GB851780A (en) * 1958-02-25 1960-10-19 Rhone Poulenc Sa New indole derivatives
US3037031A (en) * 1959-08-04 1962-05-29 Warner Lambert Pharmaceutical Derivatives of 3-(2-aminoalkyl)-5-indolol and process therefor
GB893707A (en) * 1960-03-01 1962-04-11 Roche Products Ltd Novel tryptamine derivatives and a process for the manufacture thereof
GB966562A (en) * 1961-04-06 1964-08-12 Parke Davis & Co Amine compounds and means of producing the same
US4092315A (en) * 1976-03-01 1978-05-30 Pfizer Inc. Novel crystalline forms of prazosin hydrochloride
ZA795239B (en) * 1978-10-12 1980-11-26 Glaxo Group Ltd Heterocyclic compounds
ZW19381A1 (en) * 1980-08-12 1983-03-09 Glaxo Group Ltd Heterocyclic compounds
US4803218A (en) * 1982-09-29 1989-02-07 Mcneilab, Inc. 3-aminoalkyl-1H-indole-5-urea and amide derivatives
GB8600397D0 (en) * 1986-01-08 1986-02-12 Glaxo Group Ltd Chemical compounds
DK158590D0 (da) * 1990-07-02 1990-07-02 Lundbeck & Co As H Indolderivater
US5545644A (en) * 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
US5578612A (en) * 1990-10-15 1996-11-26 Pfizer Inc. Indole derivatives
RO111767B1 (ro) * 1990-10-15 1997-01-30 Pfizer Derivati de indol, procedee si intermediari pentru prepararea acestora, compozitii farmaceutice si metoda pentru tratarea unor afectiuni
US5559246A (en) * 1990-10-15 1996-09-24 Pfizer Inc. Indole derivatives
US5559129A (en) * 1990-10-15 1996-09-24 Pfizer Inc Indole derivatives
US5208248A (en) * 1991-01-11 1993-05-04 Merck Sharpe & Dohme, Ltd. Indazole-substituted five-membered heteroaromatic compounds
CZ283018B6 (cs) * 1991-02-01 1997-12-17 Merck Sharp And Dohme Limited Deriváty imidazolu, triazolu a tetrazolu a farmaceutické přípravky na jejich bázi
JP2840448B2 (ja) * 1991-11-25 1998-12-24 フアイザー・インコーポレイテツド インドール誘導体
GB9201038D0 (en) * 1992-01-16 1992-03-11 Glaxo Group Ltd Chemical compounds
US5409941A (en) * 1992-02-03 1995-04-25 Pfizer Inc. 5-heteroyl indole derivatives
TW288010B (fr) * 1992-03-05 1996-10-11 Pfizer
SK280193B6 (sk) * 1992-04-07 1999-09-10 Pfizer Inc. Indolové deriváty predstavujúce 5-ht1 agonisty, fa
GB9207930D0 (en) * 1992-04-10 1992-05-27 Pfizer Ltd Indoles
PL172232B1 (pl) * 1992-04-10 1997-08-29 Pfizer Pochodne acyloaminoindolu PL PL PL PL PL PL PL PL
GB9208161D0 (en) * 1992-04-14 1992-05-27 Pfizer Ltd Indoles
GB9210400D0 (en) * 1992-05-15 1992-07-01 Merck Sharp & Dohme Therapeutic agents
FR2701026B1 (fr) * 1993-02-02 1995-03-31 Adir Nouveaux dérivés de l'indole, de l'indazole et du benzisoxazole, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
BR9406481A (pt) * 1993-04-22 1996-01-09 Pfizer Res & Dev Derivados de indol como agonistas do tipo 5-HT1 para utilização na enxaqueca
AP486A (en) * 1993-04-27 1996-04-16 Pfizer Indole derivatives.
AU686654B2 (en) * 1993-08-31 1998-02-12 Pfizer Inc. 5-arylindole derivatives

Also Published As

Publication number Publication date
NZ288210A (en) 1998-01-26
RO116400B1 (ro) 2001-01-30
KR970705557A (ko) 1997-10-09
FI113768B (fi) 2004-06-15
UA45980C2 (uk) 2002-05-15
CA2198599A1 (fr) 1996-03-07
OA10600A (en) 2000-04-06
WO1996006842A1 (fr) 1996-03-07
SK24897A3 (en) 1998-08-05
ZA957142B (en) 1997-02-25
LV11800A (lv) 1997-06-20
PE41596A1 (es) 1996-10-12
SA95160156B1 (ar) 2005-05-30
ES2112650T3 (es) 1998-04-01
PL180867B1 (pl) 2001-04-30
EP0776323B1 (fr) 1998-02-11
DK0776323T3 (da) 1998-03-30
BR9503812A (pt) 1996-04-16
CN1155886A (zh) 1997-07-30
SI9520091A (sl) 1998-02-28
US6110940A (en) 2000-08-29
HRP950460A2 (en) 1997-08-31
MY113733A (en) 2002-05-31
IS1850B (is) 2003-02-07
YU49287B (sh) 2005-03-15
DE69501620D1 (de) 1998-03-19
HU227822B1 (en) 2012-03-28
BG101250A (en) 1997-09-30
AU691005B2 (en) 1998-05-07
HRP950460B1 (en) 2000-02-29
AP576A (en) 1997-03-20
FI970800A (fi) 1997-02-26
CO4410334A1 (es) 1997-01-09
FI970800A0 (fi) 1997-02-26
IL115013A (en) 2000-11-21
IL115013A0 (en) 1995-12-08
KR100228952B1 (ko) 1999-11-01
JPH09512283A (ja) 1997-12-09
MX9701538A (es) 1997-05-31
BG61840B1 (bg) 1998-07-31
BRPI9503812B1 (pt) 2017-04-18
IS4401A (is) 1996-12-19
DZ1923A1 (fr) 2002-02-17
TNSN95092A1 (fr) 1996-02-06
ATE163182T1 (de) 1998-02-15
LV11800B (en) 1997-10-20
HUT77310A (hu) 1998-03-30
DE69501620T2 (de) 1998-07-02
TR199501061A2 (tr) 1996-06-21
CA2198599C (fr) 2000-06-06
JP2904588B2 (ja) 1999-06-14
AP9500754A0 (en) 1995-07-31
SK282922B6 (sk) 2003-01-09
SI9520091B (sl) 2004-10-31
NO311297B1 (no) 2001-11-12
CZ56397A3 (cs) 1998-05-13
NO970861D0 (no) 1997-02-26
EG23822A (en) 2007-09-19
GR3026475T3 (en) 1998-06-30
EP0776323A1 (fr) 1997-06-04
YU56995A (sh) 1998-07-10
RU2159241C2 (ru) 2000-11-20
GB9417310D0 (en) 1994-10-19
NO970861L (no) 1997-02-26
AU2735295A (en) 1996-03-22
US6380226B1 (en) 2002-04-30
CN1066727C (zh) 2001-06-06
CZ287693B6 (en) 2001-01-17
PL318319A1 (en) 1997-06-09

Similar Documents

Publication Publication Date Title
MA23650A1 (fr) Sels d'un derive d'indole, son procede de production et composition le contenant
DZ1880A1 (fr) Forme posologique d'azithromycine et son procédé de production.
FR2743077B1 (fr) Polyamide et un procede de fabrication de celui-ci, et des compositions le contenant
FR2498182B1 (fr) Procede de production d'amides n-substitues
MA23452A1 (fr) Procede de preparation d'agents antiparasitaires consistant en derives d'avermectines et de milbemycines.
HUP9600448A3 (en) Naphthyl compounds, pharmaceutical compositions containing them, process for producing them, their intermediates and their use
MA23942A1 (fr) Formulation nouvelle contenant de la paroxetine, et procede pour sa preparation
MA22373A1 (fr) Methode pour la production d'articles de cellulose forme
RO93871A (fr) Procede d'obtention des derives de propargyloxyacetonitryle substitus
IL124645A0 (en) Process for the production of 1, 2-bis (acyloxylates)
MA22151A1 (fr) Procede de production d'azabenzimidazoles
FR2760823B1 (fr) Procede et installation de production d'air de qualite medicale
MA24534A1 (fr) Procede pour la production d'irones
PL315422A1 (en) Novel compounds and their salts, method of obtaining them as well as pharmaceutic agent and method of obtaining same
KR0156581B1 (en) 1,4-benzothiazine-2-acetic acid derivatives and process for production
PL315479A1 (en) Novel compounds and their salts, method of obtaining them as well as pharmaceutic agent and method of obtaining same
MA23081A1 (fr) Procede de preparation de derives d'indolone
FR2663941B1 (fr) Procede de production d'organosiloxanes.
FR2555578B1 (fr) Procede de preparation de derives d'azetidinone
TR27462A (tr) Sübstitüe edilmis sinamik asidi hidroksiamid'leri, bunlarin üretilmesine mahsus usul, bunlari ihtiva eden maddeler ve bunlarin kullanilmasi.
ITRM960874A0 (it) Procedimento migliorato per la produzione di 5-idrossimetiltiazolo
NO975961D0 (no) Fremgangsmåte for fremstilling av 1-(3-trialkylsilylfenyl)-2,2,2-trifluorometyl-ethanonderivater
GB9516444D0 (en) Process for the production of n,n-dimethyl-n'-phenylureas
MA21132A1 (fr) Derive d'oxadiazolone , son procede de production et herbicide le contenant .
FR2595714B1 (fr) Procede perfectionne de production d'interleukine-0